Interesting article in PMLive magazine explores the many ways Artificial Intelligence offers potential for pharma – including for drug development, marketing and market research, and of course, the type of personalized communications we’re doing for our clients. The piece includes commentary from our own Chief Strategy & Marketing Officer, Houda Kamoun.
“As an industry, we routinely capture massive sets of data. AI allows us to put sophisticated analytics over the top of that data and use it to inform how a brand engages with its audiences at key points in their journey. We’re now able to build detailed customer personae
based not on guesswork or assumption but on real observational data.”